Clinical Trial Update: K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp [Phase 3]

View source ↗

Summary

Phase 3 trial update indicates completion of the K301 study for seborrheic dermatitis of the scalp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrheic Dermatitis

Drugs mentioned

• K301

Snippet

Sponsor: Moberg Pharma AB | Conditions: Seborrhoeic Eczema of the Scalp | Phase 3 | Status: COMPLETED